# A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

> clinical trial · VERIFIED · 2026-07-10

Status: NOT_YET_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Non-small Cell Lung Cancer

- Company: Hoffmann-La Roche
- Sector: Non-small Cell Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07541170

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.